NCT00021775

Brief Summary

The purpose of this study is to set up a system for doing research on HIV prevention in various parts of the world. In order to plan large, long-term studies on the prevention of HIV in different areas of the world, it is necessary to get certain information first. It is important to know about the rate of HIV infection and how to get people to enroll for any future studies. This study will be done at 4 study locations.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2002

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2001

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 31, 2001

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2002

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2004

Completed
Last Updated

January 3, 2014

Status Verified

December 1, 2013

First QC Date

August 4, 2001

Last Update Submit

December 31, 2013

Conditions

HIV Infections

Keywords

Risk FactorsIncidencePatient SelectionHIV Seronegativity

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants may be eligible for this study if they:
  • Are 16 (Saint Petersburg) or 18 (Xinjiang, Guangxi, and Chennai) years of age or older.
  • Are HIV sero-negative.
  • Are available for 12 months of study participation.
  • Have written consent of parent or legal guardian if under age.
  • Are able and willing to provide information on where they can be located or contacted.
  • Meet specific risk-group requirements, for women at heterosexual risk, for men at heterosexual risk, and for injection drug users.

You may not qualify if:

  • Participants will not be eligible for this study if they:
  • Have any mental disorders that would cause a problem with the informed consent or study participation.
  • Have any condition that, in the opinion of the doctor, would interfere with the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Guangxi Ctrs. for Disease Control & Prevention and for HIV/AIDS Prevention & Control CRS

Nanning, Guangxi, 530028, China

Location

Xinjiang Uygar Autonomous Region Ctr. for Disease Control & Prevention, HPTN Project Office

Ürümqi, Xinjiang, 830011, China

Location

St. Petersburg Univ. Biomedical Ctr.

Saint Petersburg, 197110, Russia

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Robert Ryder

    STUDY CHAIR

Study Design

Study Type
observational
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2001

First Posted

August 31, 2001

Study Start

April 1, 2002

Study Completion

February 1, 2004

Last Updated

January 3, 2014

Record last verified: 2013-12

Locations

CN(2)RU(1)